Last reviewed · How we verify
povidone-iodine 4%
At a glance
| Generic name | povidone-iodine 4% |
|---|---|
| Also known as | Wokadine, Pyodine |
| Sponsor | Sheba Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Surgical Site Preparation in Subjects Undergoing Medical Thoracoscopy (NA)
- CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee (NA)
- The Additive Effect of Exercise in Addition to Corticosteroid Injection in Plantar Fasciitis (NA)
- Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients
- Ozone Therapy in Lateral Epicondylopathy (NA)
- EFFECT OF PERIODONTAL TREATMENT ON ALZHEIMER DISEASE-ASSOCIATED OUTCOMES (NA)
- Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis (PHASE2)
- CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- povidone-iodine 4% CI brief — competitive landscape report
- povidone-iodine 4% updates RSS · CI watch RSS
- Sheba Medical Center portfolio CI